These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 39412922)

  • 1. The spectrum of late radiation sequelae in head and neck cancer.
    Vashistha B; Negi P; Kingsley PA
    J Cancer Res Ther; 2024 Jul; 20(5):1578-1583. PubMed ID: 39412922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of late sequelae after radiotherapy for head and neck cancer.
    Strojan P; Hutcheson KA; Eisbruch A; Beitler JJ; Langendijk JA; Lee AWM; Corry J; Mendenhall WM; Smee R; Rinaldo A; Ferlito A
    Cancer Treat Rev; 2017 Sep; 59():79-92. PubMed ID: 28759822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutrition impact symptoms and associated outcomes in post-chemoradiotherapy head and neck cancer survivors: a systematic review.
    Crowder SL; Douglas KG; Yanina Pepino M; Sarma KP; Arthur AE
    J Cancer Surviv; 2018 Aug; 12(4):479-494. PubMed ID: 29556926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes.
    Hunter KU; Schipper M; Feng FY; Lyden T; Haxer M; Murdoch-Kinch CA; Cornwall B; Lee CS; Chepeha DB; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):935-40. PubMed ID: 23040224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma.
    Thomson DJ; Ho KF; Ashcroft L; Denton K; Betts G; Mais KL; Garcez K; Yap BK; Lee LW; Sykes AJ; Rowbottom CG; Slevin NJ
    Acta Oncol; 2015 Jan; 54(1):88-98. PubMed ID: 25279959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral complications of head and neck radiotherapy: prevalence and management.
    Germano F; Melone P; Testi D; Arcuri L; Marmiroli L; Petrone A; Arcuri C
    Minerva Stomatol; 2015 Aug; 64(4):189-202. PubMed ID: 25937580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.
    Langendijk JA; Doornaert P; Verdonck-de Leeuw IM; Leemans CR; Aaronson NK; Slotman BJ
    J Clin Oncol; 2008 Aug; 26(22):3770-6. PubMed ID: 18669465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute symptoms during the course of head and neck radiotherapy or chemoradiation are strong predictors of late dysphagia.
    van der Laan HP; Bijl HP; Steenbakkers RJ; van der Schaaf A; Chouvalova O; Vemer-van den Hoek JG; Gawryszuk A; van der Laan BF; Oosting SF; Roodenburg JL; Wopken K; Langendijk JA
    Radiother Oncol; 2015 Apr; 115(1):56-62. PubMed ID: 25792467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective clinical study on long-term swallowing function and voice quality in advanced head and neck cancer patients treated with concurrent chemoradiotherapy and preventive swallowing exercises.
    Kraaijenga SA; van der Molen L; Jacobi I; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
    Eur Arch Otorhinolaryngol; 2015 Nov; 272(11):3521-31. PubMed ID: 25381096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues.
    Nguyen NP; Sallah S; Karlsson U; Antoine JE
    Cancer; 2002 Feb; 94(4):1131-41. PubMed ID: 11920484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy-Associated Saliva and Taste change Evaluation (TASTE) in head & neck cancer patients undergoing radiotherapy: a study protocol.
    Dietze A; Neyer PJ; Speth MM; Metzler P; Elicin O; Balermpas P; Aebersold DM; Riesterer O; Stieb S
    BMC Cancer; 2024 Jul; 24(1):865. PubMed ID: 39026163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
    Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
    Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swallowing functional outcomes and nutritional status in head and neck cancer radiotherapy: longitudinal study.
    Wang Y; Zhang L; Jin S; Li H; Gong L; Wang Y; Jin S; Cao Y; Shih Y; Lu Q
    BMJ Support Palliat Care; 2020 Dec; 10(4):452-461. PubMed ID: 32404303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypopharyngeal dose is associated with severe late toxicity in locally advanced head-and-neck cancer: an RTOG analysis.
    Machtay M; Moughan J; Farach A; Martin-O'Meara E; Galvin J; Garden AS; Weber RS; Cooper JS; Forastiere A; Ang KK
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):983-9. PubMed ID: 23078898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based organ-sparing radiotherapy in head and neck cancer.
    Dirix P; Nuyts S
    Lancet Oncol; 2010 Jan; 11(1):85-91. PubMed ID: 20129131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer.
    Mortensen HR; Overgaard J; Jensen K; Specht L; Overgaard M; Johansen J; Evensen JF; Andersen E; Andersen LJ; Hansen HS; Grau C;
    Acta Oncol; 2013 Oct; 52(7):1535-42. PubMed ID: 24047339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supragingival and subgingival microbiota from patients with poor oral hygiene submitted to radiotherapy for head and neck cancer treatment.
    Gaetti-Jardim E; Jardim ECG; Schweitzer CM; da Silva JCL; Oliveira MM; Masocatto DC; Dos Santos CM
    Arch Oral Biol; 2018 Jun; 90():45-52. PubMed ID: 29533791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.
    Palazzi M; Tomatis S; Orlandi E; Guzzo M; Sangalli C; Potepan P; Fantini S; Bergamini C; Gavazzi C; Licitra L; Scaramellini G; Cantu' G; Olmi P
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):330-7. PubMed ID: 17881148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Documentation and incidence of late effects and screening recommendations for adolescent and young adult head and neck cancer survivors treated with radiotherapy.
    Hamilton SN; Arshad O; Kwok J; Tran E; Fuchsia Howard A; Serrano I; Goddard K
    Support Care Cancer; 2019 Jul; 27(7):2609-2616. PubMed ID: 30467794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Acute Toxicities, Overall Treatment Time and Quality of Life in Head and Neck Cancer Patients Treated with IMRT and Helical Tomotherapy.
    R YB; Swamy K; Swaroopa C; Maiya V
    Gulf J Oncolog; 2024 May; 1(45):7-14. PubMed ID: 38774928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.